By combining two existing therapies, researchers found that they have been able to stop or reverse the progression of advanced melanoma.

“This finding provides the first clinical proof-of-concept that an immunotherapy directed against premalignant tumors can prevent cancer,” s

This particular combination has been especially gratifying because not only does the SD-101 therapy drug induce tumour shrinkage at the actu

“Our study shows that age is an important factor to consider when administering immunotherapy to melanoma patients,” said Ashani Weeraratna,

“This is a treatment that had been used fairly extensively, especially in Australia, and been published on and seemed to have a good success

"Our study suggests that assessing the abundance of macrophages and the contextual presence of CD8 T-cells—for example by measuring gen

“We think the combined use of demethylase blockers and targeted immunotherapy might be extremely effective [for treating melanoma],” said st

“Our findings challenge the previous school of thought that immunotherapy would offer little benefit to patients with desmoplastic melanoma